Affordable Access

Efficacy of a twice-daily antiretroviral regimen containing 100 mg ritonavir/400 mg indinavir in HIV-infected patients.

Authors
  • Ghosn, Jade
  • Lamotte, Claire
  • Ait-Mohand, Hocine
  • Wirden, Marc
  • Agher, Rachid
  • Schneider, Luminita
  • Bricaire, François
  • Duvivier, Claudine
  • Calvez, Vincent
  • Peytavin, Gilles
  • Katlama, Christine
Type
Published Article
Journal
AIDS
Publisher
Ovid Technologies (Wolters Kluwer) - Lippincott Williams & Wilkins
Publication Date
Jan 24, 2003
Volume
17
Issue
2
Pages
209–214
Identifiers
PMID: 12545081
Source
Medline
License
Unknown

Abstract

RTV/IDV (100/400 mg bid) yields significantly higher IDV plasma Cmin and lower IDV Cmax values relative to the standard IDV regimen, thereby improving both tolerability and efficacy.

Report this publication

Statistics

Seen <100 times